Skip to main content

Day: August 2, 2021

Kingsoft Cloud Announces Major Strategic Move in Enterprise Cloud Services

BEIJING, Aug. 02, 2021 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC), a leading independent cloud service provider in China, announced that the Company made a major strategic move in its Enterprise Cloud Services (“ECS”) business by entering into a definitive agreement to acquire controlling interests in Camelot Employee Scheme Inc. (“Camelot”). The proposed transaction is expected to bring significant synergies to the Company, in particular:By integrating Camelot’s nationwide project execution capacities and resources across major cities in China, including Beijing, Wuhan, Nanjing, Shanghai, among others, the Company expects to further accelerate and enhance the implementation of ECS projects with lower costs and improved efficiency;The senior management of Camelot, including...

Continue reading

Green Thumb Industries Closes Transaction to Acquire Vertically Integrated Cannabis Business in Rhode Island

Acquisition of one of only three vertical licenses in Rhode Island, including an operating production facility and open retail location Expands distribution footprint in highly populated New England market Increases national presence to 14 states; 61 open retail locations nationwideCHICAGO and VANCOUVER, British Columbia, Aug. 02, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, announced today it has closed on the acquisition of Mobley Pain Management and Wellness Center (DE), LLC and Canwell Processing (Rhode Island), LLC, which both held contractual interests in Summit Medical Compassion Center, Inc., a non-profit corporation with vertically integrated cannabis operations in Rhode Island....

Continue reading

BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021

Mainz, Germany, August 2, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter on Monday, August 9th, 2021. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the second quarter 2021. The slide presentation and audio of the webcast will be available via this link. To participate in the conference call, please dial the following numbers ten minutes prior to the start and provide the Conference ID:United States international: United States domestic (toll-free):Germany:Conference ID: +1 646 741 3167+1 877 870 9135+49 (0) 692 2222 6255378733Participants may...

Continue reading

Prospect Capital Corporation Preferred Stock Offering Issuances Exceed $300 Million Across Institutional, Registered Investment Advisor, Wirehouse, and Independent Private Wealth Investors

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect’s preferred stock offerings (collectively, the “Preferred Stock”) have exceeded $300 million in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020. “Prospect’s Preferred Stock has been sold across institutional, registered investment advisor, wirehouse, and independent private wealth investor channels, with significant demand due to the Preferred Stock’s investor-friendly attributes that include credit support, liquidity, and income,” said Grier Eliasek, President of Prospect. On July 12, 2021, Prospect announced the pricing of an underwritten public offering of $150 million in aggregate liquidation...

Continue reading

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease

Galafold® is the First and Only Oral Therapy Approved in the EU for the Long-term Treatment of Adolescents with Fabry Disease Aged 12 years and older with an Amenable Mutation PHILADELPHIA, Aug. 02, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced the European Commission has approved Galafold® (migalastat) for use in adolescents aged 12 to

Continue reading

Tower Semiconductor Reports Second Quarter 2021 Record Revenues; Guides Third Quarter Further Strong Revenue Growth

Second quarter 2021 revenue represents 17% total and 26% organic year over year growth, with 2021 third quarter mid-range revenue guidance of 24% total and 38% organic year over year growth MIGDAL HAEMEK, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) — Tower Semiconductor (NASDAQ: TSEM & TASE: TSEM) reports today its results for the second quarter ended June 30, 2021. HighlightsSecond quarter revenue of $362 million, reflecting record revenue for the company, with year over year 26% organic growth and 17% total growth. Significant year over year increases in gross profit, operating profit, and net profit. Guides mid-range revenue for the third quarter of 2021 of $385 million, demonstrating 24% year over year growth and 38% organic growth. Expanding the previously announced capacity expansion plan by an additional $100 million,...

Continue reading

Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

The ADC is Expected to Accelerate Development and Clinical Manufacturing of Vaccines, Including Vaccines for COVID-19, When Fully Operational CHATHAM, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it will hold a groundbreaking ceremony at the Company’s planned 45,000 square foot clinical scale manufacturing facility in the New Bedford Business Park in Massachusetts on August 3, 2021 at 11:00 a.m. ET. The new facility is expected to house Tonix’s Advanced Development Center (ADC) for accelerated research, development and analytical capabilities, as well as the production of clinical trial quality vaccines for infectious diseases, including COVID-19. The ceremony marks the formal start of site construction....

Continue reading

XPO Logistics Completes Spin-Off of GXO Logistics

GREENWICH, Conn. , Aug. 02, 2021 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO) today announced that it has completed the previously announced spin-off of GXO Logistics, Inc., creating two independent, publicly traded companies. XPO is a leading provider of freight transportation services, primarily less-than-truckload transportation and truck brokerage services, and GXO is the largest pure-play contract logistics provider in the world. XPO shares will continue to trade on the New York Stock Exchange under the symbol “XPO” and, effective today, GXO will begin “regular way” trading on the NYSE under the symbol “GXO.” Brad Jacobs, chairman and chief executive officer of XPO Logistics, said, “With the timely completion of our spin-off, XPO and GXO are moving forward with powerful momentum as independent public companies. I want...

Continue reading

R1 Appoints Jay Sreedharan as New Chief Technology and Digital Officer

Former Microsoft Azure founding member and Starbucks Executive to Accelerate R1’s Digital Growth and Innovation MURRAY, Utah, Aug. 02, 2021 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that Jay Sreedharan will join the executive team as its first chief technology and digital officer. Sreedharan will lead R1’s efforts in creating digital solutions that drive higher-value experiences for patients and providers. In this role, Sreedharan will be responsible for delivering on R1’s promise of digital transformation and growth, including strategy, engineering, product development, architecture and implementation, as well as future digital M&A and partnership activity. Sreedharan...

Continue reading

Lottery.com Issues Business Update and Provides Preliminary Second Quarter 2021 Results

AUSTIN, Texas and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — AutoLotto, Inc. (“Lottery.com”), a leading technology company that is transforming how, where and when the lottery is played and Trident Acquisitions Corp. (Nasdaq: TDACU, TDAC, TDACW) (“Trident”) today provided business update, available on Lottery.com’s Investor Relations website here. Additionally, Lottery.com provided preliminary results for second quarter 2021 revenue, which is expected to be between $9.1 million and $9.6 million on a reported basis and between $10.0 million and $10.5 million on a pro forma basis including the recently acquired interests in Juega Lotto and Aganar. This compares to $0.9 million on a reported basis in the second quarter of 2020. During the last four quarters ended June 30, 2021, sequential revenue growth averaged approximately 87%...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.